ArticleJournal of the advanced practitioner in oncology2025

Imetelstat: A First-in-Class Telomerase Inhibitor for the Treatment of Patients With Lower-Risk Myelodysplastic Syndromes and Anemia.

Hetalkumari Patel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.